BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24528821)

  • 1. Adult medulloblastoma: feasibility and effectiveness of utilising high-dose chemotherapy with autologous stem cell rescue in newly diagnosed patients.
    Collins JT; Narayana MJ; Morris K; Casey J; Inglis PL; Cheuk R; Rajah T; Robertson T; Kennedy GA
    Intern Med J; 2014 Feb; 44(2):209-10. PubMed ID: 24528821
    [No Abstract]   [Full Text] [Related]  

  • 2. Author reply: To PMID 23279053.
    Wong SF; Mak G; Rosenthal MA; Cher L; Gan HK
    Intern Med J; 2014 Feb; 44(2):210-1. PubMed ID: 24528822
    [No Abstract]   [Full Text] [Related]  

  • 3. [Medulloblastoma].
    Sato N; Sato H
    Ryoikibetsu Shokogun Shirizu; 2000; (28 Pt 3):114-20. PubMed ID: 11043200
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroimaging abnormalities in adult medulloblastoma undergoing intensified therapy.
    Secondino S; Citterio A; Pedrazzoli P; Funaioli C; Scialfa GG; Siena S
    Anticancer Res; 2008; 28(6B):3991-2. PubMed ID: 19192661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tandem high-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuro-ectodermic tumors.
    Dufour C; Kieffer V; Varlet P; Raquin MA; Dhermain F; Puget S; Valteau-Couanet D; Grill J
    Pediatr Blood Cancer; 2014 Aug; 61(8):1398-402. PubMed ID: 24664937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medulloblastoma.
    Dhall G
    J Child Neurol; 2009 Nov; 24(11):1418-30. PubMed ID: 19841429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medulloblastoma.
    Millard NE; De Braganca KC
    J Child Neurol; 2016 Oct; 31(12):1341-53. PubMed ID: 26336203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy with autologous stem cell rescue for malignant brain tumors.
    Dunkel IJ
    Cancer Invest; 2000; 18(5):492-3. PubMed ID: 10834034
    [No Abstract]   [Full Text] [Related]  

  • 9. Medulloblastoma development: tumor biology informs treatment decisions.
    Gopalakrishnan V; Tao RH; Dobson T; Brugmann W; Khatua S
    CNS Oncol; 2015; 4(2):79-89. PubMed ID: 25768332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medulloblastoma: toward biologically based management.
    Samkari A; White JC; Packer RJ
    Semin Pediatr Neurol; 2015 Mar; 22(1):6-13. PubMed ID: 25976255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences in treating medulloblastoma at the University of Minnesota hospitals.
    Smith CE; Long DM; Jones TK; Levitt SH
    Radiology; 1973 Oct; 109(1):179-82. PubMed ID: 4544581
    [No Abstract]   [Full Text] [Related]  

  • 12. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
    Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
    J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medulloblastoma/Primitive neuroectodermal tumor and germ cell tumors: the uncommon but potentially curable primary brain tumors.
    Samkari A; Hwang E; Packer RJ
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):881-95. PubMed ID: 22794288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local perspective on a rare brain tumour: adult medulloblastoma.
    Wong SF; Mak G; Rosenthal MA; Cher L; Gan HK
    Intern Med J; 2013 May; 43(5):567-72. PubMed ID: 23279053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large cell/anaplastic medulloblastoma is associated with poor prognosis-a retrospective analysis at a single institute.
    Huang PI; Lin SC; Lee YY; Ho DM; Guo WY; Chang KP; Chang FC; Liang ML; Chen HH; Liu YM; Yen SH; Wong TT; Chen YW
    Childs Nerv Syst; 2017 Aug; 33(8):1285-1294. PubMed ID: 28488086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the treatment of childhood brain tumors: no room for complacency.
    Finlay JL; Erdreich-Epstein A; Packer RJ
    Pediatr Hematol Oncol; 2007; 24(1):79-84. PubMed ID: 17130118
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
    Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
    Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe encephalopathy after high-dose chemotherapy with autologous stem cell support for brain tumours.
    van den Berkmortel F; Gidding C; De Kanter M; Punt CJ
    Anticancer Res; 2006; 26(1B):729-33. PubMed ID: 16739345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
    Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
    Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medulloblastoma and primitive neuroectodermal tumors.
    Packer RJ; Macdonald T; Vezina G; Keating R; Santi M
    Handb Clin Neurol; 2012; 105():529-48. PubMed ID: 22230517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.